Literature DB >> 8269395

Gram-negative sepsis: what dilemma?

J C Hurley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8269395      PMCID： PMC358297          DOI： 10.1128/CMR.6.4.443

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN： 0893-8512            Impact factor:   26.132


× No keyword cloud information.
  9 in total

Review 1.  Antibiotic-induced release of endotoxin: a reappraisal.

Authors:  J C Hurley
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 2.  Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.

Authors:  J D Baumgartner
Journal:  Infect Dis Clin North Am       Date:  1991-12       Impact factor: 5.982

3.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction.

Authors:  C R Raetz; R J Ulevitch; S D Wright; C H Sibley; A Ding; C F Nathan
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

Review 5.  Gram-negative sepsis: a dilemma of modern medicine.

Authors:  R C Bone
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

6.  Reappraisal of the role of endotoxin in the sepsis syndrome.

Authors:  J C Hurley
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

7.  Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group.

Authors:  C L Sprung; P N Peduzzi; C H Shatney; R M Schein; M F Wilson; J N Sheagren; L B Hinshaw
Journal:  Crit Care Med       Date:  1990-08       Impact factor: 7.598

8.  Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.

Authors:  H S Warren; S F Amato; C Fitting; K M Black; P M Loiselle; M S Pasternack; J M Cavaillon
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

9.  Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.

Authors:  J D Baumgartner; D Heumann; J Gerain; P Weinbreck; G E Grau; M P Glauser
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307
  9 in total
  1 in total

Review 1.  Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.

Authors:  J C Hurley
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.